New patent expiration for Eisai Inc drug HALAVEN

Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are two patents…

The post New patent expiration for Eisai Inc drug HALAVEN appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog